Send feedback

NPFF

gene
On this page

Also known as FMRFAL

Summary

NPFF (neuropeptide FF-amide peptide precursor, HGNC:7901) is a protein-coding gene on chromosome 12q13.13, encoding Pro-FMRFamide-related neuropeptide FF (O15130). Morphine modulating peptides.

This gene encodes a member of the FMRFamide related peptide (FARP) family of neuropeptides. The encoded preproprotein is proteolytically processed to generate multiple amidated peptides. These peptides may play a role in the regulation of heart rate and blood pressure and the modulation of morphine-induced antinociception. Patients with hypertension exhibit decreased expression of the encoded protein. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed.

Source: NCBI Gene 8620 — RefSeq curated summary.

At a glance

  • GWAS associations: 4
  • Clinical variants (ClinVar): 1 total
  • GTEx eGene: eQTL in 7 tissues, sQTL in 2 (q < 0.05)
  • Constraint (gnomAD): pLI 0.00 (LoF-tolerant), LOEUF 1.73 (unconstrained)
  • MANE Select transcript: NM_003717

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:7901
Approved symbolNPFF
Nameneuropeptide FF-amide peptide precursor
Location12q13.13
Locus typegene with protein product
StatusApproved
AliasesFMRFAL
Ensembl geneENSG00000139574
Ensembl biotypeprotein_coding
OMIM604643
Entrez8620

Gene structure

Transcript identifiers

Ensembl transcripts: 4 — 3 protein_coding, 1 retained_intron

MANE Select: ENST00000267017

Transcript support level (Ensembl TSL; 1 = fully mRNA-supported): TSL 1: 2

ENST00000267017, ENST00000448979, ENST00000940394, ENST00001142754

RefSeq mRNA: 2 — MANE Select: NM_003717 NM_001320296, NM_003717

CCDS: CCDS8862

Canonical transcript exons

ENST00000267017 — 3 exons

ExonStartEnd
ENSE000009388165350737353507484
ENSE000023822665350668853506893
ENSE000034596315350702153507142

Expression profiles

Bgee: expression breadth ubiquitous, 104 present calls, max score 90.44.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1823 / max 224.5907, expressed in 35 samples.

Highest expression (Bgee): male germ line stem cell (sensu Vertebrata) in testis, primordial germ cell in gonad, colonic epithelium, granulocyte, ganglionic eminence.

Genetic regulation across tissues (GTEx eQTL / sQTL)

NPFF is an eGene in GTEx v10 — its expression is genetically regulated (eQTL) in 7 tissues and its splicing (sQTL) in 2 (q < 0.05). Strongest associations first; slope = normalized effect of the lead variant’s alternative allele.

9 significant tissue × QTL associations:

TissueQTLq-valueSlopeLead variant
Brain Spinal cord cervical c-1eqtl1.4e-03+1.1712:53836195:C:A
Esophagus Gastroesophageal Junctioneqtl1.6e-03-0.2212:53287171:C:T
Prostateeqtl1.3e-02-0.1612:53566405:A:G
Testiseqtl1.4e-02-0.1312:53676278:C:CTG
Brain Cerebellumeqtl1.5e-02-0.1912:53957592:CG:C
Ovaryeqtl2.5e-02-0.2712:53642530:C:T
Brain Hypothalamuseqtl2.7e-02+0.5112:54443686:G:A
Brain Substantia nigrasqtl4.5e-02-3.2512:52555628:A:G
Adipose Subcutaneoussqtl4.5e-02-0.8212:53150475:T:TA

FANTOM5 promoters

1 alternative TSS:

Promoter IDTPM avgSamples expressed
1312480.182335

Top tissues by expression

showing 100 of 123 tissues by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047390.44gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099184.94gold quality
colonic epitheliumUBERON:000039760.93gold quality
granulocyteCL:000009455.36gold quality
ganglionic eminenceUBERON:000402354.55gold quality
cortical plateUBERON:000534353.57gold quality
apex of heartUBERON:000209852.85gold quality
olfactory segment of nasal mucosaUBERON:000538649.76gold quality
C1 segment of cervical spinal cordUBERON:000646949.04gold quality
stromal cell of endometriumCL:000225547.74gold quality
bone marrow cellCL:000209246.38silver quality
mucosa of transverse colonUBERON:000499146.12gold quality
duodenumUBERON:000211443.43gold quality
cerebellumUBERON:000203743.17gold quality
cerebellar cortexUBERON:000212942.76gold quality
tonsilUBERON:000237242.26silver quality
cerebellar hemisphereUBERON:000224542.02gold quality
ventricular zoneUBERON:000305341.66gold quality
prefrontal cortexUBERON:000045141.56gold quality
right hemisphere of cerebellumUBERON:001489040.75gold quality
urinary bladderUBERON:000125540.53gold quality
hindlimb stylopod muscleUBERON:000425240.38gold quality
hypothalamusUBERON:000189839.10gold quality
bone marrowUBERON:000237138.89silver quality
calcaneal tendonUBERON:000370138.72silver quality
bloodUBERON:000017837.93gold quality
liverUBERON:000210736.50gold quality
endocervixUBERON:000045835.71gold quality
muscle tissueUBERON:000238534.93gold quality
skeletal muscle tissueUBERON:000113434.89gold quality
leukocyteCL:000073834.80gold quality
monocyteCL:000057634.19gold quality
primary visual cortexUBERON:000243633.34gold quality
placentaUBERON:000198732.82gold quality
upper lobe of left lungUBERON:000895232.79gold quality
cortex of kidneyUBERON:000122532.28gold quality
frontal cortexUBERON:000187032.14gold quality
lungUBERON:000204832.07gold quality
kidneyUBERON:000211331.86gold quality
ascending aortaUBERON:000149631.56gold quality
left uterine tubeUBERON:000130331.35gold quality
thoracic aortaUBERON:000151531.31gold quality
gall bladderUBERON:000211031.28gold quality
lymph nodeUBERON:000002931.10gold quality
vermiform appendixUBERON:000115431.08gold quality
sural nerveUBERON:001548830.93gold quality
ovaryUBERON:000099230.87gold quality
islet of LangerhansUBERON:000000629.80gold quality
left ovaryUBERON:000211929.69gold quality
right lungUBERON:000216729.51silver quality
uterine cervixUBERON:000000229.50gold quality
brainUBERON:000095529.07gold quality
fallopian tubeUBERON:000388928.92gold quality
tibial arteryUBERON:000761028.92gold quality
popliteal arteryUBERON:000225028.83gold quality
left coronary arteryUBERON:000162628.62gold quality
muscle of legUBERON:000138327.96gold quality
omental fat padUBERON:001041427.71gold quality
cerebral cortexUBERON:000095627.66gold quality
adult mammalian kidneyUBERON:000008227.62gold quality
right ovaryUBERON:000211827.61silver quality
multicellular organismUBERON:000046826.96gold quality
pancreasUBERON:000126426.78gold quality
putamenUBERON:000187426.54gold quality
gastrocnemiusUBERON:000138825.67gold quality
lower esophagus muscularis layerUBERON:003583325.61silver quality
lower esophagusUBERON:001347325.53silver quality
thoracic mammary glandUBERON:000520025.45silver quality
esophagogastric junction muscularis propriaUBERON:003584125.37gold quality
dorsolateral prefrontal cortexUBERON:000983425.31gold quality
heartUBERON:000094825.19gold quality
right atrium auricular regionUBERON:000663125.13gold quality
adipose tissueUBERON:000101324.98gold quality
stomachUBERON:000094524.91silver quality
caudate nucleusUBERON:000187324.87gold quality
Brodmann (1909) area 9UBERON:001354024.46gold quality
descending thoracic aortaUBERON:000234524.30gold quality
endometriumUBERON:000129524.28gold quality
esophagusUBERON:000104324.25silver quality
muscle layer of sigmoid colonUBERON:003580524.18gold quality
superior frontal gyrusUBERON:000266124.08gold quality
adrenal glandUBERON:000236924.06gold quality
colonUBERON:000115523.89silver quality
right lobe of liverUBERON:000111423.80silver quality
intestineUBERON:000016023.68gold quality
body of stomachUBERON:000116123.62silver quality
left adrenal gland cortexUBERON:003582523.55gold quality
skin of abdomenUBERON:000141623.36gold quality
small intestineUBERON:000210823.36gold quality
Ammon’s hornUBERON:000195423.18gold quality
prostate glandUBERON:000236722.98gold quality
adrenal tissueUBERON:001830322.80gold quality
zone of skinUBERON:000001422.78silver quality
thyroid glandUBERON:000204622.70gold quality
heart left ventricleUBERON:000208422.68silver quality
nucleus accumbensUBERON:000188222.59gold quality
tibial nerveUBERON:000132322.28silver quality
ectocervixUBERON:001224922.28silver quality
temporal lobeUBERON:000187122.22gold quality
vaginaUBERON:000099622.15gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-HCAD-38no1956.73
E-ANND-3no0.00

HPA expression

RNA tissue specificity: Tissue enriched

46 HPA tissues / cells by nTPM:

Tissue / cellAxisnTPM
Epididymistissue1489.7
Cerebellumtissue30.3
Midbraintissue4.7
Spinal cordtissue4.6
Medulla oblongatatissue4.2
Corpus callosumtissue4.2
Periaqueductal graytissue4.0
Substantia nigratissue3.7
Hippocampal formationtissue3.4
Cerebral cortextissue3.3
Hypothalamustissue3.3
Insular cortextissue3.3
Retrosplenial and cingulate cortextissue3.2
Prefrontal cortextissue3.1
Ponstissue3.0
Amygdalatissue3.0
Ventral forebraintissue3.0
Septumtissue3.0
Thalamustissue2.9
Entorhinal cortextissue2.9
Motor cortextissue2.8
Olfactory bulbtissue2.8
Somatosensory cortextissue2.8
Basal gangliatissue2.7
Putamentissue2.7
Temporal cortextissue2.7
Superior colliculitissue2.6
Retrosplenial cortextissue2.4
Occipital cortextissue2.4
Locus coeruleustissue0.8
Adrenal glandtissue0.7
Seminal vesicletissue0.5
Salivary glandtissue0.5
Heart muscletissue0.3
Retinatissue0.2
Frontal cortextissue0.2
Gallbladdertissue0.2
Thymustissue0.2
Caudate putamentissue0.2
Lymph nodetissue0.1
Vaginatissue0.1
Esophagustissue0.1
Parathyroid glandtissue0.1
Urinary bladdertissue0.1
Bone marrowtissue0.1
Fallopian tubetissue0.1

Brain sub-regions (HPA Brain Atlas): detected in 66; highest nTPM — Nucleus tractus solitarii (7.6), Cervical spinal cord, central gray (6.7), Periaquaductal grey, dorsal (6.5), Cervical spinal cord, dorsal horn (5.0), Dorsal spinal cord (4.6).

Regulation

Is transcription factor: no

Upstream regulators (CollecTRI, top): KCNIP3, PDX1, POU1F1, POU2F1

Functional genomics

gnomAD constraint: pLI 6.29e-07, LOEUF 1.73, missense Z -0.0908 — population loss-of-function intolerance (pLI ≥ 0.9 = LoF-intolerant; lower LOEUF = more constrained). gnomAD

Regional missense constraint (gnomAD RMC): no regional variation along ENST00000267017 — one region, missense o/e 1.03.

Literature-anchored findings (GeneRIF, showing 7)

  • expression of hNPFF2 receptor mRNA was up-regulated by neuropeptide FF (PMID:16336216)
  • neuropeptide FF and micro-opioid receptor association could be a possible molecular basis for anti-opioid activity (PMID:17224450)
  • the findings from the early studies on the analgesic and morphine modulating activities suggested a role for NPFF in pain modulation–review (PMID:17854890)
  • reduction of NPFF release within the dorsal motor nucleus and ambiguus nucleus could serve as a possible cause of the impairment of cardiac vagal control in hypertensive patients (PMID:21120930)
  • Our results…highlight the neuropeptide FF-amide peptide encoding gene (NPFF) as a novel candidate risk gene for both migraine with aura and migraine without aura (PMID:26660531)
  • The distribution of Neuropeptide FF and Neuropeptide VF in central and peripheral tissues and their role in energy homeostasis control. (PMID:34534716)
  • Renal autocrine neuropeptide FF (NPFF) signaling regulates blood pressure. (PMID:38965251)

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_rerionpfflENSDARG00000045016
mus_musculusNpffENSMUSG00000023052
rattus_norvegicusNpffENSRNOG00000074090

Mouse-model phenotypes

Observed phenotypes of the mouse ortholog (MGI:1891708) from MGI (Alliance of Genome Resources) — knockout/mutant phenotypes, ranked by annotation count. 1 distinct phenotype terms.

Mouse phenotype (MP)Records
hyperactivity1

Additional cross-species homologs

Sequence homologs in species beyond Ensembl Compara’s model organisms, by Diamond local protein alignment (% sequence identity; best hit per species). Lower-identity rows are more distant homologs. The matched accessions’ gene symbols aren’t in biobtree yet, so each row shows the UniProt accession.

OrganismUniProtIdentityMethod
Bos taurusP15506100.0%Diamond

Genomic neighbors (locus context)

Genes flanking this one on the chromosome (NCBI/Entrez gene neighborhood). Positional context only — some neighbors share regulatory elements (bidirectional promoters, antisense/overlapping transcripts), but chromosomal adjacency is not itself a functional relationship (see Interactions for that).

SymbolTypeEntrez
ATF7-AS1ncRNA100652999
ATF7protein-coding11016
ATF7-NPFFprotein-coding114108587
ATF7-AS2ncRNA124902937
TARBP2protein-coding6895
MAP3K12protein-coding7786
AMHR2protein-coding269
PCBP2protein-coding5094
PRR13protein-coding54458
PCBP2-OT1ncRNA102157401

Protein

Protein identifiers

Pro-FMRFamide-related neuropeptide FF — O15130 (reviewed: O15130)

Alternative names: FMRFamide-related peptides

All UniProt accessions (1): O15130

UniProt curated annotations — full annotation on UniProt →

Function. Morphine modulating peptides. Have wide-ranging physiologic effects, including the modulation of morphine-induced analgesia, elevation of arterial blood pressure, and increased somatostatin secretion from the pancreas. Neuropeptide FF potentiates and sensitizes ASIC1 and ASIC3 channels.

Subcellular location. Secreted.

Similarity. Belongs to the FARP (FMRFamide related peptide) family.

Isoforms (2)

UniProt IDNamesCanonical?
O15130-11yes
O15130-22

RefSeq proteins (2): NP_001307225, NP_003708* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR008065NPFFFamily

Pfam: PF15085

UniProt features (11 total): peptide 3, propeptide 2, modified residue 2, signal peptide 1, sequence variant 1, region of interest 1, splice variant 1

Structure

Experimental structures (PDB)

1 structures by resolution:

PDBTitleMethodResolution (Å)
9JFYCryo-EM structure of Neuropeptide FF receptor 2 in complex with hNPSF and GiELECTRON MICROSCOPY3.21

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-O15130-F163.920.04

Antibody-complex structures (SAbDab)

1 antibodies co-crystallized with this protein: 9JFY

Human Protein Atlas

Protein class: Predicted secreted proteins

Protein evidence: Evidence at protein level

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (2)

TypePositions
Phenylalanine amide76, 110

Function

Pathways and Gene Ontology

Reactome pathways

2 curated (TAS) of 8; 0 disease pathways. Curated-first; evidence = TAS (manually curated) vs IEA (electronic inference).

8 pathways:

IDPathwayEvidence
R-HSA-416476G alpha (q) signalling eventscurated
R-HSA-389397Orexin and neuropeptides FF and QRFP bind to their respective receptorscurated
R-HSA-373076Class A/1 (Rhodopsin-like receptors)—
R-HSA-388396GPCR downstream signalling—
R-HSA-500792GPCR ligand binding—
R-HSA-375276Peptide ligand-binding receptors—
R-HSA-162582Signal Transduction—
R-HSA-372790Signaling by GPCR—

MSigDB gene sets: 176 (showing top): GOBP_SPINAL_CORD_DEVELOPMENT, MORF_ITGA2, GOBP_MEMBRANE_DEPOLARIZATION, GOBP_REGULATION_OF_BLOOD_PRESSURE, MORF_MSH3, GOBP_CIRCULATORY_SYSTEM_PROCESS, GOBP_INFLAMMATORY_RESPONSE, GOCC_SECRETORY_GRANULE, GOBP_INSULIN_SECRETION, MORF_BRCA1, GOBP_REGULATION_OF_HORMONE_LEVELS, GOBP_NEGATIVE_REGULATION_OF_PEPTIDE_SECRETION, GOBP_RESPONSE_TO_FOOD, GOBP_HORMONE_TRANSPORT, GOBP_REGULATION_OF_MEMBRANE_DEPOLARIZATION

GO Biological Process (15): acute inflammatory response to antigenic stimulus (GO:0002438), regulation of membrane depolarization (GO:0003254), positive regulation of cytosolic calcium ion concentration (GO:0007204), neuropeptide signaling pathway (GO:0007218), chemical synaptic transmission (GO:0007268), response to xenobiotic stimulus (GO:0009410), negative regulation of heart rate (GO:0010459), spinal cord development (GO:0021510), vasopressin secretion (GO:0030103), negative regulation of appetite (GO:0032099), positive regulation of blood pressure (GO:0045777), negative regulation of insulin secretion (GO:0046676), excitatory postsynaptic potential (GO:0060079), maternal process involved in female pregnancy (GO:0060135), somatostatin secretion (GO:0070253)

GO Molecular Function (4): G protein-coupled receptor binding (GO:0001664), signaling receptor binding (GO:0005102), neuropeptide hormone activity (GO:0005184), neuropeptide activity (GO:0160041)

GO Cellular Component (7): extracellular region (GO:0005576), dendrite (GO:0030425), perikaryon (GO:0043204), axon terminus (GO:0043679), postsynapse (GO:0098794), neuronal dense core vesicle (GO:0098992), vesicle (GO:0031982)

Reactome top-level categories

6 top-level categories:

CategoryPathways
Signaling by GPCR2
Peptide ligand-binding receptors1
GPCR downstream signalling1
Signal Transduction1
GPCR ligand binding1
Class A/1 (Rhodopsin-like receptors)1

GO top-level categories

41 GO namespaces:

CategoryTerms
cellular anatomical structure3
peptide hormone secretion2
inflammatory response to antigenic stimulus1
acute inflammatory response1
regulation of membrane potential1
regulation of cellular process1
membrane depolarization1
regulation of biological quality1
G protein-coupled receptor signaling pathway1
anterograde trans-synaptic signaling1
response to chemical1
regulation of heart rate1
negative regulation of heart contraction1
central nervous system development1
animal gross anatomical part developmental process1
negative regulation of response to food1
regulation of appetite1
regulation of blood pressure1
insulin secretion1
negative regulation of protein secretion1
regulation of insulin secretion1
negative regulation of peptide hormone secretion1
regulation of postsynaptic membrane potential1
chemical synaptic transmission, postsynaptic1
female pregnancy1
multicellular organismal reproductive process1
signaling receptor binding1
protein binding1
hormone activity1
neuropeptide activity1
receptor ligand activity1
neuropeptide receptor binding1
neuron projection1
dendritic tree1
neuronal cell body1
neuron projection terminus1
presynapse1
distal axon1
synapse1
dense core granule1
membrane-bounded organelle1

Experimentally-supported GO annotations

GO terms backed by direct experimental evidence (ECO experimental codes) — 2 of 27 annotations. The rest are phylogenetic / computational / electronic (IEA).

2 experimentally-supported GO terms:

GO termNSEvidence
neuropeptide signaling pathwayBPdirect assay
neuropeptide activityMFdirect assay

Protein interactions and networks

STRING

showing 15 of 428 interactions by confidence (×1000):

Protein AProtein BPartner UniProtScore
NPFFNPFFR1Q9GZQ6970
NPFFNPFFR2Q9Y5X5965
NPFFMAS1P04201954
NPFFPRLHP81277906
NPFFPRLHRP49683868
NPFFMRGPRDQ8TDS7858
NPFFMRGPRX2Q96LB1852
NPFFMRGPRX3Q96LB0849
NPFFMRGPRGQ86SM5827
NPFFMRGPRX4Q96LA9825
NPFFMRGPRFQ96AM1824
NPFFMRGPRX1Q96LB2820
NPFFNPVFQ9HCQ7813
NPFFQRFPP83859757
NPFFMAS1LP35410725

IntAct

Human interaction partners of NPFF in IntAct, one row per partner (best MIscore; records = supporting IntAct interaction records).

1 partners by confidence:

PartnerInteraction typeMIscoreRecords
ZDHHC17physical association0.3701

BioGRID (2 interactions; top human partners by supporting records): RNF123 (Affinity Capture-MS), ZDHHC17 (Two-hybrid)

SIGNOR signaling

2 signaling interactions:

AEffectBMechanism
NPFFup-regulatesNPFFR1binding
NPFFup-regulatesNPFFR2binding

Ligand–receptor pairs (CellPhoneDB) (2)

Curated ligand–receptor partners (cell-cell communication), distinct from the protein–protein interactions above.

2 ligand–receptor pairs:

PartnerThis gene’s roleSignaling class
NPFFR2ligandSignaling by Neuropeptide precursor
NPFFR1ligandSignaling by Neuropeptide precursor

Disease & clinical

Genetic variants

Variant evidence for NPFF: 1 ClinVar records (0 pathogenic / likely pathogenic); 4 GWAS associations.

ClinVar

1 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance0
Likely benign0
Benign0

SpliceAI

Top 10 splice-impact sites by Δscore (adjacent positions with the same effect merged into one range; 27 predictions of 115):

Position(s)EffectΔscoreSites
12:53507371–53507372donor_loss0.99005
12:53507371donor_loss0.9800
12:53507019–53507020donor_loss0.95004
12:53507020donor_loss0.9400
12:53507161acceptor_gain0.9400
12:53507150acceptor_gain0.9200
12:53506894–53506895acceptor_loss0.90006
12:53507368donor_loss0.8700
12:53507143–53507144acceptor_loss0.86006
12:53507149acceptor_gain0.8600

AlphaMissense

99 missense substitutions predicted likely pathogenic (of 723 scored), across 24 residues. Top 20 hotspot residues, ranked by the number of likely-pathogenic substitutions (of those reachable by a single-nucleotide change), then by mean score:

ResidueLikely-pathogenic substitutionsMean am_pathogenicityMax am_pathogenicity
F11070.9410.987
F7670.9120.981
F7170.7710.864
G11160.8650.928
K11360.8190.886
R7560.8010.900
P7360.7700.836
F10150.8660.889
K11250.8250.906
R10950.7800.929
W10250.7560.846
Q10850.7480.949
P10750.7220.806
F6940.8160.880
Q7440.7600.921
G7740.7310.828
S10330.7170.717
R7830.7020.727
A10510.9070.907
A10610.7290.729

HPA cancer prognostics

RNA cancer specificity: Cancer enriched (Testicular Germ Cell Tumor)

Disease associations

OMIM: gene MIM:604643 | disease phenotypes:

GWAS associations

4 associations:

StudyTraitp-value
GCST005956_63Waist-to-hip ratio adjusted for BMI4e-13
GCST005962_45Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)7e-13
GCST005958_17Waist-to-hip ratio adjusted for BMI (age >50)1e-8
GCST005957_8Waist-to-hip ratio adjusted for BMI (age <50)6e-6

EFO canonical traits (from GWAS)

3 canonical traits:

EFO IDTrait name
EFO:0007788BMI-adjusted waist-hip ratio
EFO:0008007age at assessment
EFO:0008343sex interaction measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (CPIC guideline: no)

CTD chemical–gene interactions

11 total (human), top 11 by PubMed support.

ChemicalActions (top 5)PubMed papers
bisphenol Aincreases expression1
CGP 52608affects binding, increases reaction1
bisphenol Saffects cotreatment, decreases expression1
jinfukangincreases expression1
Benzo(a)pyreneincreases methylation1
Dexamethasonedecreases expression, affects cotreatment1
Indomethacinaffects cotreatment, decreases expression1
Tobacco Smoke Pollutiondecreases expression1
Urethanedecreases expression1
1-Methyl-3-isobutylxanthineaffects cotreatment, decreases expression1
Particulate Matterdecreases expression1

Clinical trials (associated diseases)

Via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.